SmarterDividends
HNSP

Hansoh Pharmaceutical Group Company Limited

HNSPF

Healthcare · Stock · monthly payer

$4.25

Overvalued · -59% Add to Portfolio

Forward Yield

1.46%

Annual Dividend

$0.06

Payout Ratio

36%

5-Yr Growth

Ex-Date

Sep 22, 2026

Frequency

Monthly

Summary

As of September 2026, Hansoh Pharmaceutical Group Company Limited (HNSPF) yields 1.46% ($0.06 per share annually), with a blended fair-value estimate of $1.74 — -59% downside, so it screens as overvalued. Dividend safety grade: C (58/100). 2 years of dividend growth.

Is HNSPF a good dividend stock?

Yes, with caveats

Hansoh Pharmaceutical Group Company Limited (HNSPF) pays a monthly dividend yielding 1.46% ($0.06/yr), with 2 years of growth and a dividend-safety grade of C. It's a solid income payer, but check the caveats below before buying.

Advantages

  • Never cut its dividend on record
  • Comfortable payout ratio (36%)

Risks

  • Single-stock concentration risk — diversify

Key Data

Dividend Yield
1.46%
Payout Ratio
36%
Annual Dividend
$0.06
5-Yr Avg Growth
Ex-Dividend Date
Sep 22, 2026
Years of Growth
2
Frequency
monthly
Beta
0.56
Market Cap
$25.8B
P/E Ratio
30.4
5-Yr Total Return
52-Week Range
$3.83 – $5.16
Dividend Safety
C · 58/100
Ever Cut?
No
HNSPF ex-dividend date & scheduleNext ex-date Sep 22, 2026 · full ex-dividend historyView →

Frequently Asked Questions